logo
Questions? +1 (202) 335-3939 Login
Set Up FREE Account Submit Release
Trusted News Since 1995
A service for healthcare industry professionals · Friday, January 10, 2025 · 775,762,726 Articles · 3+ Million Readers
Home  •••  Newswires by Industry  •  Countries  •  U.S. States  •  World Media Directory
Healthcare Industry News  •••  Topics  •  Countries  •  U.S. States

Macular Degeneration News Monitoring

  • Published on 05:19 GMT

    Base Editing Addresses Inherited Macular Degeneration in Primate, Human Tissue Models

    A collaboration between scientists at the Institute of Molecular and Clinical Ophthalmology Basel (IOB) and Beam Therapeutics has resulted in a new base editing therapy for Stargardt disease, the most common form of inherited macular degeneration. Details …

    Source: Genetic Engineering and Biotechnology News - Label Pending
  • Published on 07:35 GMT

    Rapid Visual Field Loss Found in Some Patients in the OHTS

    Despite being healthy young volunteers who were being studied in a prospective fashion, a portion of patients in the well-known OHTS still developed primary open-angle glaucoma that progressed at a very rapid rate. More than 20 years ago, the first …

    Source: Review of Ophthalmology - Neutral
  • Published on 07:35 GMT

    IOL Calculation in Eyes With Corneal Dystrophy

    Scientists evaluated the accuracy of several intraocular lens formulas for patients with endothelial dystrophy without edema, treated with cataract surgery alone, at an academic tertiary referral center, as part of a comparative retrospective cohort study. …

    Source: Review of Ophthalmology - Neutral
  • Published on 00:53 GMT

    Soliddd debuts smart glasses for people with low vision, AMD

    January 09, 2025 1 min read Add topic to email alerts Subscribe We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio At CES 2025, Soliddd, an optical …

    Source: Healio News - Neutral
  • Published on 07:35 GMT

    Bausch + Lomb Gets FDA Approval for enVista Envy IOLs

    Intraocular Lenses Bausch + Lomb Gets FDA Approval for enVista Envy IOLs Bausch + Lomb announced the FDA approved the enVista Envy intraocular lens, which the company says offers a continuous range of vision with excellent dysphotopsia tolerance.  A …

    Source: Review of Ophthalmology - Neutral
  • Published on 01:17 GMT

    Anemiaprin Reviews 2025: A Closer Look at Its Blood Sugar and Wellness Claims

    When it comes to maintaining optimal health, our blood plays a crucial role. It acts as the body’s transportation system, delivering essential nutrients and oxygen to every cell while removing waste products. For individuals struggling with blood-related …

    Source: South Whidbey Record - Washington State - Label Pending
  • Published on 01:40 GMT

    [Must-Know Facts] NativePath Antarctic Krill Oil: Side Effects, Pricing, and User Feedback

    In today’s fast-paced world, maintaining optimal health has become more important than ever. With the rise of chronic ailments and lifestyle-related health issues, many individuals are turning to dietary supplements to support their wellbeing. One such …

    Source: Vashon-Maury Island Beachcomber - Washington State - Label Pending
  • Published on Jan 6, 2025

    Soliddd introduces smart glasses to enable vision for people with macular degeneration

    SolidddVision smartglasses, the first true vision correction for people living with vision loss due to macular degeneration, is making its debut at CES 2025. Macular degeneration is an eye disease that makes it hard for people to see what’s in front of …

    Source: VentureBeat - Neutral
  • Published on Jan 9, 2025

    U.S. FDA Confirms Class 1 Resubmission of the Supplemental New Drug Application for IZERVAY™ (avacincaptad pegol ...

    TOKYO, Jan. 8, 2025 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced the U.S. Food and Drug Administration (FDA) accepted the revised supplemental New Drug Application (sNDA) …

    Source: The Alexander City Outlook - Alabama - Neutral
  • Published on Jan 6, 2025

    Soliddd is building smart glasses for people with macular degeneration

    For the past several years, the halls of the Las Vegas Convention Center have been lousy with AR/VR/XR smart glasses. While the some of the biggest names in tech, like Apple and Google, have struggled to gain traction in the category, accessible …

    Source: Yahoo News - United Kingdom - Label Pending
  • Published on Jan 9, 2025

    Management of macular telangiectasia type 2 may be near

    January 09, 2025 3 min read Macular telangiectasia type 2 is a progressive and relatively rare neurodegenerative disease of the macula that typically affects patients who are older than 40 years of age, more predominantly women. Initially, macular …

    Source: Healio News - Neutral
  • Published on Jan 9, 2025

    Evolution of AI in ophthalmology

    January 09, 2025 4 min read Throughout history, all medical decision-making has relied upon anecdote, expert opinion, and cumbersome and limited clinical trials with delayed or nonexistent post hoc analysis and validation. More recently with the advent of …

    Source: Healio News - Neutral
  • Published on Jan 9, 2025

    Roundtable addresses ROP screening, fellowship training efforts

    A study published in 2023 that analyzed more than 23 million births found that the proportion of premature infants diagnosed with retinopathy of prematurity nearly doubled in the U.S. from 2003 to 2019.Led by Section Editor Robert S. Gold, MD, Healio | OSN …

    Source: Healio News - Neutral
  • Published on Jan 9, 2025

    Aflibercept 8 mg for RVO Hits Primary Endpoint in Phase 3 QUASAR Trial

    Aflibercept 8 mg injection (EYLEA HD) met its primary endpoint in the Phase 3 QUASAR trial, achieving improved vision with extended dosing among a population with macular edema following retinal vein occlusion (RVO).1 Announced by Regeneron, on December 17 …

    Source: HCPLive - Label Pending
  • Published on Jan 9, 2025

    Aviceda Therapeutics Secures $207.5 Million to Advance AVD-104 for Geographic Atrophy

    Aviceda Therapeutics has successfully closed a $207.5 million Series C financing round to advance its lead treatment candidate, AVD-104, into a pivotal Phase 3 clinical trial for geographic atrophy (GA) secondary to advanced age-related macular …

    Source: Ophthalmology Breaking News - Neutral
  • Published on Jan 9, 2025

    6 Eye-Friendly Vitamins and Supplements That Will Safeguard Your Vision

    Whether you have vision problems or spend your days staring at a computer screen, everyone should pay attention to their eyes. The top vitamins for eye health are essential to keeping them healthy and your vision clear. Eating a balanced diet is the best …

    Source: Cnet - Neutral
  • Published on Jan 9, 2025

    FDA Accepts Revised Avacincaptad Pegol sNDA for Geographic Atrophy

    The US Food and Drug Administration (FDA) has accepted the revised supplemental new drug application (sNDA) for avacincaptad pegol intravitreal solution (IZERVAY) to treat geographic atrophy (GA) secondary to age-related macular degeneration (AMD).1 …

    Source: HCPLive - Label Pending
  • Published on Jan 9, 2025

    The good, the bad and the hilarious

    Breadcrumb Trail Links Opinion Column Margaret Haylock Capon Margaret Haylock CaponAdvertisement 2 This advertisement has not loaded yet, but your article continues below. Article content Article content Recommended Videos Article content My friend Linda …

    Source: The Standard Freeholder - Neutral
  • Published on Jan 9, 2025

    New Research, Plus CES Intros, Show Growth Of Wearables For Health

      Within 10 years, 50% of Americans over 55 years old will use wearable devices daily to forecast life-threatening health risks, predicts consulting firm ScienceSoft in a new study based on an analysis of statistical platforms, consumer surveys and other …

    Source: MediaPost - Neutral

03 days 20:03:29

Featured Releases

Got News to Share? · Submit · See All
Got news to share? Submit it now.
Load more healthcare industry news or search news using your own keywords. There are 775,762,726 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Healthcare Industry News by Country >
Healthcare Industry News by U.S. State >
Healthcare Industry News Topics >
Online News Publications >
World News Report >

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter >
Create RSS Feed >
NewsPlugin for WordPress >

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire >
Events >

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 12/19/2024

World Media Directory >

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All
Got news to share? Submit it now.

Healthcare & Pharmaceuticals Events

See All

No event was found.

Become a Member - Join Today!
Join thousands of professionals. Stay current. Stay competitive.
  • Track news from thousands of sources
  • Submit news sources for inclusion in our news tracking algorithm
  • Build your own customized email newsletters
  • Use of our RSS Feeds
  • Includes a complimentary EIN Presswire account plus 1-free release
  • Uncluttered & advertising free news pages

Healthcare Industry Today by EIN Newsdesk & EIN Presswire (a press release distribution service)

Follow us on Facebook and connect with us on LinkedIn

Newsmatics Inc., 1025 Connecticut Avenue NW, Suite 1000, Washington, DC 20036 · Contact · About

© 1995-2025 Newsmatics Inc., a publisher of EIN News · All Rights Reserved · Privacy Policy · User Agreement